Stock Market Today (LIVE): Spotify Races Into Fitness With Peloton; AI's Moment of Truth Arrives This Week
Apr 27, 2026 by Matthew BenjaminThe Fed Meets on Rates This Week. What Should Investors Expect?The Fed is unlikely to cut its target interest rate at this week's monetary policy meeting.
Apr 27, 2026 by Selena MaranjianOne Growth Stock Every Investor Should Own Right Now -- No DebateYou may not think of it as a growth stock, but it has averaged annual gains of 18% over the past decade.
Apr 27, 2026 by David Jagielski, CPATim Cook Is Stepping Down. Is Apple's Stock in Trouble?John Ternus will become Apple's new CEO as of Sept. 1.
Apr 27, 2026 by Matthew BenjaminThe Fed Meets on Rates This Week. What Should Investors Expect?The Fed is unlikely to cut its target interest rate at this week's monetary policy meeting.
Apr 27, 2026 by Selena MaranjianOne Growth Stock Every Investor Should Own Right Now -- No DebateYou may not think of it as a growth stock, but it has averaged annual gains of 18% over the past decade.
Apr 27, 2026 by David Jagielski, CPATim Cook Is Stepping Down. Is Apple's Stock in Trouble?John Ternus will become Apple's new CEO as of Sept. 1.
Apr 27, 2026 by David Jagielski, CPANetflix Co-Founder Reed Hastings Is Leaving the Company. What Does This Mean for the Stock?The departure comes after Netflix recently abandoned efforts to acquire Warner Bros.
Apr 27, 2026 by Andy GouldProfit-Taking or Pivot? Adams Asset Advisors Sells $50M in Calumet Shares After a Nearly 200% RunCalumet, Inc. produces specialty branded products and renewable fuels for industrial and consumer markets across North America and beyond.
Apr 27, 2026 by Rick OrfordThis AI Stock Just Got a Huge Boost From Meta and MicrosoftThis AI company just signed major AI cloud deals, but the real opportunity lies in what happens next. Here's the bullish case, the risks, and why the stock still has investors split.
Apr 27, 2026 by Geoffrey SeilerIs ServiceNow Stock a Buy After Shares Sink?The company's shares plunged despite a solid quarter and raised guidance.
Apr 27, 2026 by James BrumleyWhy Sagimet Biosciences Stock Is Soaring TodayThe biopharma company confirmed it's still aiming at the United States' acne-treatment market.
Apr 27, 2026 by Jeremy BowmanWhy Arm Holdings Stock Was Tumbling TodayAfter surging in sympathy with Intel last Friday, Arm gave up some of those gains today.
Apr 27, 2026 by Neil PatelAre International Markets Worth Investing In for U.S. Investors?Diversifying a portfolio from a geographical perspective is probably something many investors aren't thinking about.
Apr 27, 2026 by Jake LerchInvestment Manager Sells 67,000 Shares of Coal Stock, According to Recent SEC FilingCore Natural Resources is a U.S.-based coal producer with integrated mining and export operations serving domestic and global markets.
Apr 27, 2026 by Anthony Di PizioElon Musk Just Delivered Great News for Tesla, but Don't Rush to Buy the StockDespite a series of positive developments, Tesla stock might still be too expensive to buy right now.
Apr 27, 2026 by Rich SmithWhy Marvell Technology Stock Just DroppedMaybe Poet shouldn't have rushed so fast to print?
Apr 27, 2026 by Eric TrieRIA Advisory Group Initiates Position in First Eagle Overseas Equity ETF, According to Recent SEC FilingThe First Eagle Overseas Equity ETF (FEOE) takes a selective approach to international investing, focusing on companies priced below their long-term value. That discipline can appeal to investors seeking overseas exposure without fully tracking broad market swings.
Apr 27, 2026 by David DierkingWhat Is One of the Best ETFs to Own for the Next 10 Years?U.S. stocks and the S&P 500 may no longer be the most attractive option in the years ahead.
Apr 27, 2026 by Maurie BackmanThink a Roth Conversion Is a No-Brainer? Here's When It Can Seriously Backfire.Don't assume it's the right move for you.
Apr 27, 2026 by David Jagielski, CPARevolution Medicines Has a Market Cap of $29 Billion and Generates No Revenue. Here's Why Its Valuation May Not Be as Ridiculous as It SeemsThe company has multiple drugs in its pipeline that could generate billions in revenue.
Apr 27, 2026 by Stefon WaltersAmazon's Core Businesses Just Keep Getting Stronger -- This Is the Growth Powerhouse I'd Hold Through Any Market CrashIt's built to weather any storm that comes its way.
Apr 27, 2026 by Cory RenauerA Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 MillionKailera Therapeutics, a clinical-stage biotech focused on obesity treatments, just reported a notable insider buy in recent SEC filings.
